Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Market Cap

Avadel Pharmaceuticals has a market cap or net worth of $940.30 million as of June 6, 2025. Its market cap has decreased by -38.86% in one year.

• Market Cap: 940.30M
• Enterprise Value: 914.20M
• 1-Year Change: -38.86%
• Ranking: #2476
• Category: Small-Cap
• Stock Price: $9.72

Market Cap Chart

Since December 31, 2002, Avadel Pharmaceuticals's market cap has increased from $70.50M to $940.30M, an increase of 1,233.76%. That is a compound annual growth rate of 12.23%.

Market Cap History

Date	Market Cap	% Change
Jun 6, 2025	940.30M	-7.16%
Dec 31, 2024	1.01B	-20.13%
Dec 29, 2023	1.27B	186.71%
Dec 30, 2022	442.30M	-6.63%
Dec 31, 2021	473.70M	21.68%
Dec 31, 2020	389.30M	37.71%
Dec 31, 2019	282.70M	196.02%
Dec 31, 2018	95.50M	-70.71%
Dec 29, 2017	326.10M	-23.90%
Dec 30, 2016	428.50M	-12.68%
Dec 31, 2015	490.70M	11.85%
Dec 31, 2014	438.70M	118.37%
Dec 31, 2013	200.90M	165.74%
Dec 31, 2012	75.60M	-41.12%
Dec 30, 2011	128.40M	-22.88%
Dec 31, 2010	166.50M	-7.04%
Dec 31, 2009	179.10M	89.93%
Dec 31, 2008	94.30M	-60.61%
Dec 31, 2007	239.40M	-66.28%
Dec 29, 2006	710.00M	72.88%
Dec 30, 2005	410.70M	-1.49%
Dec 31, 2004	416.90M	-3.92%
Dec 31, 2003	433.90M	515.46%
Dec 31, 2002	70.50M	-

View and export this data all the way back to 2002. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	689.60B
Johnson & Johnson	372.22B
AbbVie	336.06B
Novo Nordisk	324.15B
UnitedHealth Group	272.23B
Abbott Laboratories	233.09B
Novartis AG	230.96B
AstraZeneca	225.55B